Questions Help Find AIDS Patients Who Are Vulnerable to Drug Resistance
May 28, 2009
Due to cost and technology limitations, HIV/AIDS patients in Africa rarely undergo testing to determine whether they are developing resistance to first-line medicines.
Treatment failure was predicted by having ever missed two days of medicine and having ever had a 30 percent decline in CD4 count, the researchers found, recommending that viral load testing -- if available -- be done on those patients first.
The study, "Development and Evaluation of a Clinical Algorithm to Monitor Patients on Antiretrovirals in Resource-Limited Settings Using Adherence, Clinical and CD4 Cell Count Criteria," was published in the Journal of the International AIDS Society (2009; doi:10.1186/1758-2652-12-3).
New York Times
05.19.2009; Donald G. McNeil Jr.
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.